Results 201 to 210 of about 179,181 (243)

Subtype-dependent PD-L1 stability and immune context shape immunotherapy response in hepatocellular carcinoma. [PDF]

Front Immunol
Grisetti L, Garcia CJC, Tarchi P, Tiribelli C, Pascut D.   +4 more
europepmc   +1 more source

PD-L1 expression and soluble PD-L1 production in gastric cancer

, 2020
openaire   +1 more source

TRIM28‐Derived Peptide Exerts Anti‐Tumor Roles by Stabilizing Tumor Suppressive BRD7 Protein in Multiple Cancers

Advanced Science, EarlyView.
An α‐helical peptide, TAB12, designed to mimic the TRIM28 binding interface, competitively disrupts the TRIM28‐BRD7 interaction, thereby blocking ubiquitin‐mediated degradation of the tumor suppressor BRD7. This stabilization unleashes potent anti‐tumor effects across multiple tumor types with a favorable safety profile, offering a feasible strategy ...
Qingqing Wei, Changning Xue, Mengna Li, Jianxia Wei, Lemei Zheng, Shipeng Chen, Yijie Wang, Yumei Duan, Yanwei Luo, Wei Xiong, Ming Zhou   +10 more
wiley   +1 more source

Telomere damage enhances immunogenicity of neuroblastoma and accelerates response to anti-PD-L1 treatment. [PDF]

Oncoimmunology
Höppner S, Werr L, Szilagyi B, Bartenhagen C, Hellmann AM, Rosswog C, Linden E, Primke G, Kahlert Y, Ibruli N, Hemstedt N, Lorenz W, Brägelmann J, Hölzel M, Fischer M.   +14 more
europepmc   +1 more source

Functional Suitability Evaluation of Radioimmunoconjugates of Nanobodies against PD-L1 and HER2/neu for Tumor Theranostics. [PDF]

Sovrem Tekhnologii Med
Avrov KO, Shatik SV, Shashkova OA, Pinevich AA, Terekhina LA, Gryazeva IV, Zaitsev VV, Berlina MA, Stanzhevsky AA, Samoylovich MP.   +9 more
europepmc   +1 more source

Bridging B-cell autoimmunity and oncology: the PD-1/PD-L1 paradox in systemic lupus erythematosus. [PDF]

Front Immunol
Guan Y, Chen C, Hou Y.
europepmc   +1 more source

High expression of STAT3 and PD-L1 predicts poor prognosis for laryngeal squamous cell carcinoma. [PDF]

Sci Rep
Shui T, Pan Y, Hong J.
europepmc   +1 more source

Interest of PD-L1 in the management of triple negative breast cancers in Ivorian patients. [PDF]

BMC Womens Health
Diallo A, Aman NA, Traore B, Coulibaly ZI, Kouacou BFA, Nzi MR, Doukoure B, Diomande MI.   +7 more
europepmc   +1 more source